首页> 外文期刊>Experimental and therapeutic medicine >Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: A double-blind randomized clinical study
【24h】

Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: A double-blind randomized clinical study

机译:依托咪酯和丙泊酚麻醉在老年胃镜检查中的安全性和有效性:双盲随机临床研究

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of the present study is to compare the safety, efficacy and cost effectiveness of anesthetic regimens by compound, using etomidate and propofol in elderly patients undergoing gastroscopy. A total of 200 volunteers (65-79 years of age) scheduled for gastroscopy under anesthesia were randomly divided into the following groups: P, propofol (1.5-2.0 mg/kg); E, etomidate (0.15-0.2 mg/kg); P+E, propofol (0.75-1 mg/kg) followed by etomidate (0.075-0.1 mg/kg); and E+P, etomidate (0.075-0.01 mg/kg) followed by propofol (0.75-1 mg/kg). Vital signs and bispectral index were monitored at different time points. Complications, induction and examination time, anesthesia duration, and recovery and discharge time were recorded. At the end of the procedure, the satisfaction of patients, endoscopists and the anesthetist were evaluated. The recovery (6.1 +/- 1.2 h) and discharge times (24.8 +/- 2.8 h) in group E were significantly longer compared with groups P, P+E and E+P (P<0.05). The occurrence of injection pain in group P+E was significantly higher compared with the other three groups (P<0.05). In addition, the incidence of myoclonus and post-operative nausea and vomiting were significantly higher in group P+E compared with the other three groups (P<0.05). There was no statistical difference among the four groups with regards to the patients' immediate, post-procedure satisfaction (P>0.05). Furthermore, there was no difference in the satisfaction of anesthesia, as evaluated by the anesthetist and endoscopist, among the four groups (P>0.05). The present study demonstrates that anesthesia for gastroscopy in elderly patients can be safely and effectively accomplished using a drug regimen that combines propofol with etomidate. The combined use of propofol and etomidate has unique characteristics which improve hemodynamic stability, cause minimal respiratory depression and less side effects, provide rapid return to full activity and result in high levels of satisfaction.
机译:本研究的目的是比较依托咪酯和丙泊酚在老年胃镜检查患者中采用复方麻醉药的安全性,有效性和成本效益。计划在麻醉下进行胃镜检查的200名志愿者(65-79岁)随机分为以下几组:P,丙泊酚(1.5-2.0 mg / kg); E,依托咪酯(0.15-0.2 mg / kg); P + E,丙泊酚(0.75-1 mg / kg),然后依托咪酯(0.075-0.1 mg / kg); E + P,依托咪酯(0.075-0.01 mg / kg),然后是异丙酚(0.75-1 mg / kg)。在不同时间点监测生命体征和双谱指数。记录并发症,诱导和检查时间,麻醉时间以及恢复和出院时间。在手术结束时,评估患者,内镜医师和麻醉师的满意度。与P,P + E和E + P组相比,E组的恢复时间(6.1 +/- 1.2 h)和放电时间(24.8 +/- 2.8 h)明显更长(P <0.05)。 P + E组注射痛的发生率明显高于其他三组(P <0.05)。此外,与其他三组相比,P + E组肌阵挛的发生率,术后恶心和呕吐的发生率显着更高(P <0.05)。四组患者的手术后即刻满意度和术后满意度无统计学差异(P> 0.05)。此外,麻醉组和内镜组评估的麻醉满意度在四组之间没有差异(P> 0.05)。本研究表明,使用丙泊酚与依托咪酯合用的药物疗法可以安全有效地完成老年患者的胃镜麻醉。丙泊酚和依托咪酯的组合使用具有独特的特征,可改善血液动力学稳定性,使呼吸抑制作用降至最低且副作用较小,可迅速恢复至完全活动状态并带来较高的满意度。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号